Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesAnemia, AplasticTransplantation ConditioningHematopoietic Stem Cell TransplantationLeukemiaLiver TransplantationTransplantation ChimeraTissue DonorsGraft SurvivalBusulfanBone Marrow PurgingHistocompatibility TestingHematopoietic Stem CellsHistocompatibilityCyclophosphamideTransplantation, IsogeneicBone Marrow DiseasesKidney TransplantationHematopoiesisRecurrenceCombined Modality TherapyMice, Inbred C57BLRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBone Marrow ExaminationLeukemia, Myeloid, AcuteTreatment OutcomeImmunosuppressive AgentsRemission InductionTime FactorsHematologic NeoplasmsGraft RejectionPrecursor Cell Lymphoblastic Leukemia-LymphomaBone RemodelingHepatic Veno-Occlusive DiseaseLaboratoriesBone Marrow NeoplasmsTransplantation ImmunologyGraft vs Host ReactionLeukemia, MyeloidImmunosuppressionStem Cell TransplantationLymphocyte DepletionAcute DiseaseLeukocyte TransfusionLymphoma, Non-HodgkinHeart TransplantationSevere Combined ImmunodeficiencyChimeraColony-Forming Units AssayT-LymphocytesRetrospective StudiesSurvival AnalysisHLA AntigensMyelodysplastic SyndromesLung TransplantationHematologic DiseasesCyclosporineActuarial AnalysisBone DensityLymphocyte TransfusionAntineoplastic Combined Chemotherapy ProtocolsNuclear FamilyCarmustineOrgan TransplantationPancytopeniaFollow-Up StudiesGraft vs Tumor EffectCell DifferentiationLeukocyte CountGraft vs Leukemia EffectSurvival RateCytarabineCytomegalovirus InfectionsBone ResorptionSpleenGranulocyte Colony-Stimulating FactorMice, Inbred BALB CMelphalanDisease-Free SurvivalEtoposideFlow CytometryLymphomaMultiple MyelomaCells, CulturedFatal OutcomePrognosisAntigens, CD34Hodgkin DiseaseMice, KnockoutInfectionCell TransplantationGranulocytes